written on 27.03.2014

Merck, GlaxoSmithKline halt copay help for Obamacare patients


Merck and GlaxoSmithKline have nixed their copay assistance for Obamacare patients. The two companies say they fear subsidizing patients' drug purchases will run afoul of federal anti-kickbacks law. But many other top drugmakers- including Novartis, Sanofi and Eli Lilly–will keep their copay cards and discounts, at least for now.